4:["$","div",null,{"className":"max-w-2xl mx-auto space-y-8","children":[["$","div",null,{"className":"space-y-3","children":[["$","div",null,{"className":"flex items-center gap-3","children":[["$","span",null,{"className":"bg-[#14b8a6] text-zinc-950 text-xs font-bold px-2 py-0.5 rounded","children":["DAY ",24]}],["$","span",null,{"className":"text-zinc-500 text-sm","children":"Monday, August 31, 2026"}]]}],["$","h1",null,{"className":"text-3xl font-bold","children":"Day 24: Holding"}],["$","p",null,{"className":"text-zinc-400 text-lg leading-relaxed border-l-2 border-[#fa8072] pl-4","children":"Day 24 — BPC-157 only, regimen unchanged."}]]}],["$","article",null,{"className":"prose-dark space-y-4 text-zinc-300 leading-relaxed","dangerouslySetInnerHTML":{"__html":"

Day 24. August 31st, 2026. Arizona.

Injection — morning:

BPC-157: 10 units (500mcg), subcutaneous.

Food: Not itemized. Same pattern as the preceding week.

Supplements: Usual stack, in transition.

→ Doses, brands, and cofactors: Supplement Stack

Wound: No specific update logged.

\n"}}],["$","div",null,{"className":"border-t border-zinc-800 pt-6","children":["$","a",null,{"href":"/blog","className":"text-[#14b8a6] hover:underline text-sm","children":"← Back to Journal"}]}]]}] 9:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"Day 24: Holding | Peptide Research"}],["$","meta","3",{"name":"description","content":"Real-time documentation of BPC-157 + TB-500 therapy for DVT, poor circulation, and chronic Achilles wound healing. Not medical advice — personal research journal."}],["$","meta","4",{"property":"og:title","content":"Peptide Research Journal"}],["$","meta","5",{"property":"og:description","content":"One man's real-time experiment with BPC-157 and TB-500 to he